DISSOLUTION RATE ENHANCEMENT OF FEBUXOSTAT BY LIQUISOLID TECHNIQUE

Abstract

The objective of this present study was to enhance the dissolution rate of poorly soluble drug Febuxostat by delivering the drug as a liquisolid compact. 
Febuxostat tablet was prepared by Liquisolid compacts technique and it is optimized by using different concentration of drug in non-volatile solvent 
(PEG400) and different ratio of Carrier (Avicel 102) to adsorbent material (Aerosil 200). The solid state property of liquisolid compact powder was 
characterized by Fourier Transform Infra-Red Spectroscopy (FT-IR). FTIR studies of Febuxostat and Liquisolid compact powder confirmed that the 
drug was pure and there is no chemical interaction between drug and excipients. The prepared Liquisolid Tablets were evaluated for hardness, Friability, 
drug content and in vitro dissolution study. The solubility and dissolution rate were found significantly increased in these Liquisolid compact systems 
compared with pure drug alone. The highest improvement of solubility and dissolution rate was found with 45% w/w Concentration of drug in PEG 
400 and 10:1 ratio of carrier to adsorbent material. The dissolution studies for liquisolid compacts and conventional formulations were also been 
performed and it was found that liquisolid compacts of Febuxostat showed significant higher drug release than conventional. Total of nine formulations 
were prepared and from that F2 was optimized formulation with drug release of 99.11%.